This company listing is no longer active
Winsan (Chengdu) Medical Science And Technology Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Winsan (Chengdu) Medical Science And Technology's earnings have been declining at an average annual rate of -31.8%, while the Healthcare Services industry saw earnings growing at 19% annually. Revenues have been declining at an average rate of 32.7% per year.
Información clave
-31.8%
Tasa de crecimiento de los beneficios
-31.6%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare Services | 14.5% |
| Tasa de crecimiento de los ingresos | -32.7% |
| Rentabilidad financiera | -18.8% |
| Margen neto | -83.4% |
| Próxima actualización de resultados | 31 Aug 2023 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Winsan (Chengdu) Medical Science And Technology. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 23 | 44 | -37 | 26 | 0 |
| 31 Dec 22 | 46 | -35 | 27 | 0 |
| 30 Sep 22 | 57 | 7 | 25 | 0 |
| 30 Jun 22 | 47 | 0 | 22 | 0 |
| 31 Mar 22 | 46 | 2 | 20 | 0 |
| 31 Dec 21 | 44 | 7 | 13 | 0 |
| 30 Sep 21 | 39 | 8 | 10 | 0 |
| 30 Jun 21 | 49 | 15 | 13 | 0 |
| 31 Mar 21 | 51 | 12 | 14 | 0 |
| 31 Dec 20 | 49 | 10 | 17 | 0 |
| 30 Sep 20 | 72 | -40 | 37 | 2 |
| 30 Jun 20 | 73 | -64 | 43 | 4 |
| 31 Mar 20 | 121 | -70 | 60 | 6 |
| 31 Dec 19 | 132 | -70 | 67 | 9 |
| 30 Sep 19 | 206 | 11 | 73 | 8 |
| 30 Jun 19 | 213 | 25 | 70 | 8 |
| 31 Mar 19 | 209 | 25 | 65 | 8 |
| 31 Dec 18 | 207 | 20 | 66 | 9 |
| 30 Sep 18 | 146 | 22 | 53 | 9 |
| 30 Jun 18 | 142 | 62 | 54 | 15 |
| 31 Mar 18 | 117 | 48 | 53 | 13 |
| 31 Dec 17 | 108 | 45 | 57 | 9 |
| 30 Sep 17 | 110 | -7 | 65 | 8 |
| 30 Jun 17 | 100 | -57 | 74 | 0 |
| 31 Mar 17 | 90 | -48 | 82 | 0 |
| 31 Dec 16 | 91 | -55 | 88 | 0 |
| 30 Sep 16 | 70 | -84 | 104 | 0 |
| 30 Jun 16 | 63 | -84 | 100 | 0 |
| 31 Mar 16 | 54 | -79 | 93 | 0 |
| 31 Dec 15 | 50 | -70 | 80 | 0 |
| 30 Sep 15 | 68 | -18 | 55 | 0 |
| 30 Jun 15 | 188 | 28 | 58 | 0 |
| 31 Mar 15 | 183 | 28 | 51 | 0 |
| 31 Dec 14 | 183 | 26 | 52 | 0 |
| 30 Sep 14 | 158 | -17 | 65 | 0 |
| 30 Jun 14 | 54 | -64 | 63 | 0 |
| 31 Mar 14 | 111 | -59 | 65 | 0 |
| 31 Dec 13 | 264 | -58 | 65 | 0 |
| 30 Sep 13 | 708 | 23 | 57 | 0 |
| 30 Jun 13 | 688 | 27 | 51 | 0 |
| 31 Mar 13 | 679 | 38 | 53 | 0 |
| 31 Dec 12 | 524 | 34 | 58 | 0 |
| 30 Sep 12 | 299 | 29 | 53 | 0 |
| 30 Jun 12 | 304 | 23 | 53 | 0 |
Ingresos de calidad: 600767 is currently unprofitable.
Margen de beneficios creciente: 600767 is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 600767 is unprofitable, and losses have increased over the past 5 years at a rate of 31.8% per year.
Acelerando crecimiento: Unable to compare 600767's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: 600767 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-23.9%).
Rentabilidad financiera
Alta ROE: 600767 has a negative Return on Equity (-18.77%), as it is currently unprofitable.